Human leukocyte antigen genotype and risk of HIV disease progression before and after initiation of antiretroviral therapy
about
Immunogenetics of small ruminant lentiviral infectionsSurvival and HLA-B*57 in HIV/HCV Co-Infected Patients on Highly Active Antiretroviral Therapy (HAART).Interplay between HIV-1 and Host Genetic Variation: A Snapshot into Its Impact on AIDS and Therapy Response.Plasma HIV-1 Tropism and the Risk of Short-Term Clinical Progression to AIDS or DeathFc gamma receptor 3A polymorphism and risk for HIV-associated cryptococcal diseaseHLA B*5701 status, disease progression, and response to antiretroviral therapyAssociation of self-reported race with AIDS death in continuous HAART users in a cohort of HIV-infected women in the United StatesHLA-B*57 Allele Is Associated with Concomitant Anti-tuberculosis and Antiretroviral Drugs Induced Liver Toxicity in Ethiopians.The emerging role of leukocyte immunoglobulin-like receptors (LILRs) in HIV-1 infection.Do HIV-specific CTL continue to have an antiviral function during antiretroviral therapy? If not, why not, and what can be done about it?Human leucocyte antigen class I and II imputation in a multiracial population.Association of a 3' Untranslated Region Polymorphism in PCSK9 with HIV Viral Load and CD4+ Levels in HIV/Hepatitis C Virus Co-Infected Women.Natural Killer Cell Interactions with Classical and Non-Classical Human Leukocyte Antigen Class I in HIV-1 Infection.
P2860
Q34434913-6618113E-FB5A-4DDF-B213-8CBFC1D5D2BDQ35737580-00AE14C2-DE5C-4E35-8455-793A294D059BQ35993707-DC091447-F7C9-4529-85DE-884E67E25ADFQ36262454-ABE43536-03B9-4955-BA4B-C1F73DBB6FC7Q37140093-87A5B029-AFAE-490A-89F5-C49BD0B953BBQ37272625-BDAEC439-F081-41CC-B172-6678B8382323Q37272859-E5DEDE35-CEDD-4F13-8358-9957C36518B7Q37667333-4CB206AA-C7B8-4FED-9B6A-B83DC39FF378Q37949561-1D35CE8E-2C78-4664-B4FE-59A341C09AA9Q38086435-682A9B4C-5B55-4291-AF5E-D8270F398BA7Q39255932-66354831-7C74-433D-AFCE-09D1CFA558CFQ41934639-72B4573A-4D5C-4C76-B893-A3DE73C56469Q46722989-40C75783-E05A-49CB-8E00-295FC629C6DE
P2860
Human leukocyte antigen genotype and risk of HIV disease progression before and after initiation of antiretroviral therapy
description
2011 nî lūn-bûn
@nan
2011 թուականի Օգոստոսին հրատարակուած գիտական յօդուած
@hyw
2011 թվականի օգոստոսին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
name
Human leukocyte antigen genoty ...... tion of antiretroviral therapy
@ast
Human leukocyte antigen genoty ...... tion of antiretroviral therapy
@en
type
label
Human leukocyte antigen genoty ...... tion of antiretroviral therapy
@ast
Human leukocyte antigen genoty ...... tion of antiretroviral therapy
@en
prefLabel
Human leukocyte antigen genoty ...... tion of antiretroviral therapy
@ast
Human leukocyte antigen genoty ...... tion of antiretroviral therapy
@en
P2093
P2860
P50
P356
P1433
P1476
Human leukocyte antigen genoty ...... tion of antiretroviral therapy
@en
P2093
Andrea Kovacs
Darlene Marti
Howard D Strickler
Howard Minkoff
Kathryn Anastos
Mardge H Cohen
Mark H Kuniholm
Mary A Young
Ruth M Greenblatt
Xiaojiang Gao
P2860
P304
10826-10833
P356
10.1128/JVI.00804-11
P407
P577
2011-08-17T00:00:00Z